A SAD, MAD and Food Effect Study to Evaluate the Safety, Tolerability, PK, and PD of AJA001 in Healthy Subjects
PHASE1CompletedINTERVENTIONAL
Enrollment
64
Participants
Timeline
Start Date
September 13, 2023
Primary Completion Date
March 26, 2024
Study Completion Date
May 15, 2024
Conditions
Healthy Volunteers
Interventions
DRUG
AJA001
AJA001
OTHER
Placebo
Placebo
Trial Locations (1)
4006
Q-Pharm Pty Ltd, Brisbane
All Listed Sponsors
lead
AJNA Australia Pty Ltd
INDUSTRY
NCT06019065 - A SAD, MAD and Food Effect Study to Evaluate the Safety, Tolerability, PK, and PD of AJA001 in Healthy Subjects | Biotech Hunter | Biotech Hunter